Doorgaan naar inhoud

Oncologie (pediatrie)

Geïndividualiseerde/aangepaste chemotherapie (aangepaste of vertraagde dosering)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (opent nieuw venster)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Bron‎: N Engl J Med 1998;338(8):499-505.

Geïndexeerd‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (opent nieuw venster)

Childhood cancer and the Jehovah's Witness faith. (opent nieuw venster)

Frankel LS, Damme CJ, Eys JV.

Bron‎: Pediatrics 1977;60(6):916-21.

Geïndexeerd‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (opent nieuw venster)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (opent nieuw venster)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Bron‎: J Clin Oncol 2004;22(24):4888-92.

Geïndexeerd‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (opent nieuw venster)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (opent nieuw venster)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Bron‎: JAMA Oncol 2022;8(1):79-87. 

Geïndexeerd‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (opent nieuw venster)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (opent nieuw venster)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Bron‎: Haematologica 2000;85(11):1221-2.

Geïndexeerd‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (opent nieuw venster)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (opent nieuw venster)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Bron‎: Bone Marrow Transplant 2016;51(7):1002-3.

Geïndexeerd‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (opent nieuw venster)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (opent nieuw venster)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Bron‎: Bone Marrow Transplant 2003;32(4):433-6.

Geïndexeerd‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (opent nieuw venster)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (opent nieuw venster)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Bron‎: Bone Marrow Transplant 2005;36(8):715-20.

Geïndexeerd‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (opent nieuw venster)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (opent nieuw venster)

Zwaan CM, Kaspers GJ

Bron‎: Br J Haematol 2004;127(3):264-79.

Geïndexeerd‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (opent nieuw venster)